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Abstract
Balancing systemic iron levels within narrow limits is critical for maintaining human health. There are no known pathways to
eliminate excess iron from the body and therefore iron homeostasis is maintained by modifying dietary absorption so that it
matches daily obligatory losses. Several dietary factors can modify iron absorption. Polyphenols are plentiful in human diet
and many compounds, including quercetin – the most abundant dietary polyphenol – are potent iron chelators. The aim of
this study was to investigate the acute and longer-term effects of quercetin on intestinal iron metabolism. Acute exposure
of rat duodenal mucosa to quercetin increased apical iron uptake but decreased subsequent basolateral iron efflux into the
circulation. Quercetin binds iron between its 3-hydroxyl and 4-carbonyl groups and methylation of the 3-hydroxyl group
negated both the increase in apical uptake and the inhibition of basolateral iron release, suggesting that the acute effects of
quercetin on iron transport were due to iron chelation. In longer-term studies, rats were administered quercetin by a single
gavage and iron transporter expression measured 18 h later. Duodenal FPN expression was decreased in quercetin-treated
rats. This effect was recapitulated in Caco-2 cells exposed to quercetin for 18 h. Reporter assays in Caco-2 cells indicated
that repression of FPN by quercetin was not a transcriptional event but might be mediated by miRNA interaction with the
FPN 39UTR. Our study highlights a novel mechanism for the regulation of iron bioavailability by dietary polyphenols.
Potentially, diets rich in polyphenols might be beneficial for patients groups at risk of iron loading by limiting the rate of
intestinal iron absorption.
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Introduction
Iron is an essential transition metal that plays an important role
in all mammalian organisms. It is incorporated into a diverse array
of proteins, including the oxygen carriers haemoglobin and
myoglobin, cytochrome complexes involved in electron transfer
in the mitochondria, and enzymes participating in nucleic acid
processing such as ribonucleotide reductase [1,2]. Balancing
systemic iron levels within narrow limits is critical for human
health, as both iron deficiency and iron overload leads to serious
haematological, metabolic and neurodegenerative disorders. In
mammals there are no known pathways to eliminate excess iron
from the body and therefore iron homeostasis is maintained by
modifying dietary absorption so that it matches daily obligatory
losses [1].
There are two forms of dietary iron, haem and non-haem iron.
Non-haem iron is the major dietary form but its bioavailability
depends on presence of other dietary factors which either enhance
or inhibit absorption in the duodenum [3,4]. Non-haem iron is
present almost entirely in the ferric (Fe3+) form; however, to be
bioavailable it must first be reduced to ferrous (Fe2+). This is
achieved by the combined action of duodenal cytochrome b
(Dcytb), a ferri-reductase which resides on the apical membrane of
duodenal enterocytes [5,6], or exogenous dietary reducing agents,
such as ascorbic acid (reviewed in [4]). Reduced iron is then
transported across the membrane into the enterocyte via the apical
iron transporter, divalent metal transporter-1 (DMT1) [7].
Subsequently, ferrous iron is transferred across the basolateral
membrane of the enterocyte via the iron exporter, ferroportin
(FPN) [8–10] and re-oxidized by ferroxidase hephaestin [11] on
the basolateral surface, prior to loading onto transferrin.
In addition to enhancers of iron bioavailability there are a
number of dietary components that act as potent inhibitors of
intestinal iron absorption, including phytic acid and polyphenolic
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compounds [4]. Polyphenols are natural products, which are
abundant in food of plant origin, and are thus an integral part of
our diet. Dietary polyphenols are receiving increasing attention
due to their proven health benefits for a variety of disorders [12].
The inhibitory potential of flavonoid polyphenols on non-haem
iron absorption in duodenum has been demonstrated both in vivo
and in vitro [13–17]. These studies provide convincing evidence
that polyphenols modify intestinal iron absorption in single meal
studies in human volunteers and acute in vitro experiments;
however, the longer-term effect of consuming elevated levels of
polyphenolic compounds on iron status is less clear. It is possible
that chronic consumption of diets poor in iron and rich in
inhibitors of iron bioavailability could contribute to the burden of
iron deficiency in certain population groups. However, there may
be benefits of consuming a polyphenol-enriched diet for groups at
risk of iron loading, for example patients with hereditary
haemochromatosis.
The flavonol quercetin is the most abundant dietary flavonoid
and is especially enriched in onions, tea and apples [18]. It is
conservatively estimated that humans consume approximately 40
– 80 mg of flavonoids/day [19]; and that quercetin contributes
approximately 25% of total flavonoid intake (i.e. 10–20 mg/day)
[20]. In common with most polyphenols, quercetin is found almost
exclusively in foods as glycoside conjugates but can be converted
rapidly into the aglycone in the intestinal lumen via the actions of
glycosidases [21,22]. In this study we have investigated the acute
and longer-term effects of quercetin on iron metabolism in vivo (in
rats) and in vitro (Caco-2 cells).
Material and Methods
Animals and treatments
Rats were supplied by the Comparative Biology Unit, Royal
Free Campus, UCL Medical School, London, UK. All experi-
mental procedures were approved by the University College
London local animal ethics committee and were conducted in
accordance with the UK Animals (Scientific Procedures) Act,
1986. After weaning (three weeks old) Sprague-Dawley male rats
were placed on low iron (25 ppm) diet for two weeks and allowed
free access to water throughout. At the end of the experimental
procedure animals were killed by administering a terminal dose of
pentobarbitone sodium (120 mg/Kg body weight).
Acute effects of quercetin on iron uptake
For acute studies, rats were anesthetized with 60 mg/Kg
pentobarbitone sodium IP and 5 cm long segments of duodenum
(starting 1 cm distal to the pylorus) were cannulated and rinsed
free of their contents with warm saline (0.9% w/v of NaCl),
followed by air. Uptake buffer (200 mL), containing Na-HEPES
(14.6 mmol/L), NaCl (127.4 mmol/L), KCl (3.2 mmol/L), ascor-
bic acid (4.0 mmol/L), 59FeCl3 (0.2 mmol/L) and 1 mmol/L of
either quercetin (Sigma-Aldrich, UK) (Q) or 3-O-methylquercetin
(Extrasynthese, France) (3MQ) or 49-O-methylquercetin (Extra-
synthese) (49MQ) or quercetin 3,49-dimethylquercetin (ABCR
GmbH, Germany) (3,49dMQ) or penta-methylquercetin (Extra-
synthese) (PMQ) (Stock solutions prepared in DMSO:ethanol
[1:1]) was instilled into the duodenal segment, which was then tied
off. In control groups, DMSO:ethanol (1:1) was added to buffer
instead of the polyphenols. Structures of polyphenolic compounds
are shown in Figure S1. Rat body temperature was maintained at
37uC using a thermostatically controlled heating blanket. After 30
minutes, blood samples (#2 mL) were collected via cardiac
puncture and the segment of duodenum was removed and washed
with approximately 40 mL of solution containing 154 mmol/L
NaCl, 0.1 mmol/L ascorbic acid, 0.01 mmol/L FeCl3 to displace
any 59Fe bound to the mucosal surface. Subsequently, the
duodenal mucosa was scraped away, the blood and mucosa
samples were weighed and gamma counted for determination of
59Fe activity. Results were expressed as percentage of absorbed
radioactive iron retained in duodenal mucosa or transferred to
blood. The percentage of 59Fe transferred to the entire blood
volume of the animal was calculated using the equation: total
blood volume = (body weight*0.06) +0.77 [23].
Effects of oral gavage of quercetin on iron metabolism
In order to investigate the longer-term effects of quercetin
administration on non-haem iron absorption, animals were
gavaged with a single dose of quercetin (50 mg/kg dissolved in
10% DMSO) or vehicle (control) eighteen hours before experi-
ments. Animals were anesthetized with pentobarbitone sodium
(60 mg/Kg body weight) injected IP. The duodenum and liver
were collected, snap frozen in liquid N2, and stored at 280uC for
real-time PCR analysis and tissue non-haem iron determination.
RNA extraction and RT-PCR
Duodenal RNA was extracted with TRIzol (Invitrogen)
according to the manufacturer’s instructions. Total RNA (1 mg)
was reverse transcribed using the Verso cDNA reverse transcrip-
tion kit (Thermo-Fisher Scientific), according to the manufactur-
er’s instructions. Real-time PCR reactions were performed using a
Roche Lightcycler using GAPDH as internal standard. Each
reaction was performed in duplicate and contained 10 pmol of
specific primers (Table S1), 16SYBR Green Mastermix (Qiagen),
and 1 mL of cDNA in a 20 mL reaction. Samples without cDNA
were included as negative controls. Cycle threshold (Ct) values
were obtained for each gene of interest and the GAPDH internal
standard. Gene expression was normalized to GAPDH and
represented as DCt values. For each sample the mean of the DCt
values was calculated. Relative gene expression was normalized to
1.0 (100%) of controls.
Levels of tissue non-haem iron
Quantitative measurement of non-haem iron was performed
according to the modified method of Torrance and Bothwell [24].
Briefly, 20–50 mg of duodenum was dried at 55uC for 72 hours
and subsequently weighed. Dried samples were digested in 1 mL
acid mixture (30% (v/v) HCl and 10% (w/v) trichloroacetic acid)
at 65uC for 20 hours. 1 mL of chromogen reagent (0.1% (w/v)
bathophenanthrolinesulfonate; 1% (v/v) thioglycolic acid in 50%
(w/v) sodium acetate solution) and samples were incubated at
37uC for 10 minutes, after which the absorbance of samples and
iron standards was measured at 535 nm. Results were reported as
mg iron/g tissue dry weight.
Serum biochemistry
Serum iron and transferrin saturation were measured using a
commercial ferrozine-based colorimetric assay according to the
manufacturer’s instructions (Pointe Scientific, USA).
Cell culture
Caco-2 TC7 cells were originally obtained from Drs Monique
Rousset and Edith Brot-Laroche (CRC, Jussieu, Paris) [25] and
have been characterised for studies on iron transport [26]. Cells
(passages 40-45) were seeded onto Transwell inserts in 6-well
plates at a density of 40,000 cells per well and cultured for 19 d in
DMEM containing 10% foetal bovine serum.
Quercetin and Intestinal Iron Absorption
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e102900
For acute uptake studies, cells were pre-treated with quercetin
(10 or 100 mmol/L) for 15 min to permit equilibration in uptake
buffer; quercetin remained present during the uptake assay. For
chronic studies, cells were exposed for 18 h at their apical surface
to quercetin. However, prior to uptake measurements, the
incubation medium was discarded and cells were washed to
remove quercetin.
In vitro iron transport
Iron uptake was measured as described previously [27]. Briefly,
a transepithelial pH gradient was established by adding Mes-
buffered saline (pH 5.5; 140 mmol/L NaCl, 5 mmol/L KCl,
1 mmol/L Na2HPO4, 1 mmol/L CaCl2, 0.5 mmol/L MgCl2,
5 mmol/L glucose, and 10 mmol/L Mes) and adding Hepes-
buffered saline (pH 7.5; same ionic composition but containing
10 mmol/l Hepes in place of Mes and 0.2% bovine serum
albumin) to the basolateral chamber. Studies were initiated by the
addition of 10 mmol/L 55FeCl3 complexed with 1 mmol/L
ascorbic acid to the apical well of the Transwell plate. Uptake
into the cells was measured over 20 min. To measure iron efflux,
cells were incubated for 1 h in buffer containing 55FeCl3, washed
and placed in fresh medium, and incubated for a further 2 h at 37
C. At the end of the experiments cells were washed thoroughly in
uptake buffer containing iron and solubilized in 0.2 mmol/L
NaOH. Basolateral medium from efflux assays was collected and
aliquots of the solubilized cell fraction and basolateral medium
were subjected to liquid scintillation counting. Data were
normalized to amounts of total protein/well.
PCR
Total RNA was isolated from cells cultured for 18 h in the
presence of quercetin using TRIzol. Following first strand cDNA
synthesis, expression levels of iron transporter mRNA and
GAPDH mRNA (used as a housekeeping gene) were analysed
by real-time quantitative PCR using an ABI Prism 7700HT
Sequence Detection System and a Power SYBR Green PCR
master mix kit (Applied Biosystems Cheshire, UK). The primer
sequences used for each gene are given in Table S1. Quantitative
measurements of iron transporter relative to GAPDH gene
expression were derived using the DCt method. Data have been
normalised to the untreated control group in each experiment and
are presented as the mean 6 S.E.M.
Western blotting
Caco-2 cells were harvested into ice-cold lysis buffer (PBS
containing 1% sodium dodecyl sulphate and 10 mg/L protease
inhibitor cocktail) and homogenized by repeated passing through
at 25-gauge needle. Protein samples (40 mg) were solubilised in
sample loading buffer and subjected to polyacrylamide gel
electrophoresis. Following immobilization on nitrocellulose, the
proteins were exposed to commercially available antibodies to
either DMT1 (NRAMP24A; 1:1000 dilution, Alpha Diagnostics,
TX, USA), FPN (MTP11A, 1:1000 dilution, Alpha Diagnostics) or
b-actin (1:1000 dilution, Sigma-Aldrich). Cross-reactivity was
observed using a horseradish peroxidase-linked secondary anti-
body (Dako) and ECL Plus (GE Healthcare).
Cell ferritin levels
Cells were incubated with 10 mmol/L FeCl3 in the presence or
absence of quercetin (0.1–10 mmol/L) for 18 h. Cells were washed
with PBS before being lysed in ice-cold lysis buffer (10 mmol/L
Tris-HCl, pH 7.5, 50 mmol/L NaCl, 1% Triton X-100, 10 mg/L
protease inhibitor cocktail). 20 mg of cellular protein was used to
measure cell ferritin using a commercially available ELISA kit
(RAMCO Laboratories).
Reporter assays
FPN 59-promoter-luciferase constructs were provided by Drs D-
L Zhang and T. Rouault (National Institute of Child Health and
Human Development, USA). MISSION FPN 39-UTR-Renilla
luciferase reporter construct was purchased from Sigma-Aldrich
UK. Caco-2 cells were seeded in 24-well plates and grown to 60-
80% confluence. Cells were transfected with reporter constructs
and control plasmids using FuGENE HD transfection reagent
(Promega UK). After 24 h, cells were treated with quercetin
(10 mmol/L) for 18 h and luciferase activity measured (in
duplicate, in 3 plates of cells, repeated in at least 2 individual
passages; n = 6–9) using a Promega dual-luciferase reporter assay
system.
Statistics
All data are expressed as means + SEM. Statistical analysis was
carried out using SigmaPlot (version 12, Systat Software Inc. IL,
USA). Student’s unpaired t-test or one-way ANOVA followed by
Tukey’s post-hoc test were used where appropriate to detect
statistical differences (P,0.05) between control and test groups.
Results
Acute exposure to quercetin increases apical iron uptake
but decreases basolateral iron efflux
To investigate the acute effects of quercetin on duodenal iron
absorption, the in situ duodenal loop method was used [28] where
either quercetin (aglycone) or methylated quercetin isoforms were
introduced into rat duodenum together with radioactive iron. In
the presence of quercetin, 3MQ, 49MQ or 3,49dMQ, but not
PMQ, there was a significant increase in mucosal 59Fe uptake
compared with the untreated control group (Figure 1A). The
increase in uptake was significantly higher in the presence of
quercetin aglycone and 49MQ compared with the other methyl-
ated forms. In contrast, 59Fe release from the intestinal mucosa
into the blood was significantly diminished in the presence of
quercetin and 49MQ compared with other methylated-quercetin
compounds and the untreated controls (Figure 1B).
The acute stimulation of iron uptake as well as inhibition of iron
efflux in the presence of quercetin aglycone was recapitulated in
intestinal Caco-2 cell monolayers (Figure 1C,D).
Quercetin decreases intestinal FPN expression
18 hours after oral administration of a single dose of quercetin,
quantitative RT-PCR analysis of rat duodenal iron transporters
revealed significant down regulation of DMT1 and FPN mRNA
levels (Figure 2A). In the same animals there was a significant
increase in non-haem iron content of the duodenum, a significant
decrease in serum iron and transferrin saturation and a decrease in
liver hepcidin mRNA expression (60%) which did not reach
statistical significance compared with control animals (Table 1).
To distinguish between the direct effects of quercetin on iron
transporter expression, and possible indirect influences resulting
from either increased duodenal iron content or changes in
hepcidin levels, we employed Caco-2 cells as a model of human
intestinal epithelial cells. In contrast to data from rat studies, there
was no effect of quercetin on DMT1 mRNA or protein levels in
Caco-2 cells (Figure 2B,D). However, FPN mRNA and protein
expression were decreased significantly by exposure to quercetin in
a dose-dependent manner (Figure 2C,E).
Quercetin and Intestinal Iron Absorption
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To determine the cellular effects of quercetin on iron transport,
Caco-2 cells were washed to remove any residual lumenal
quercetin and placed in fresh quercetin-free uptake buffer prior
to measurement of iron transport. The initial rate of iron uptake
into cells was not significantly altered following quercetin
treatment (Figure 3A). However, there was a significant decrease
in iron efflux into the basolateral medium in cells exposed to
quercetin (Figure 3B).
To investigate the cellular fate of cellular iron in quercetin-
treated Caco-2 cells we measured cell ferritin content (the main
cellular iron storage molecule). Following exposure to quercetin
there was a significant decrease in ferritin protein levels (Figure 4).
Quercetin did not alter FPN 59-promoter activity in Caco-
2 cells
Next we investigated whether the inhibitory effects of quercetin
on FPN protein and mRNA were mediate via altered gene
transcription. Two FPN mRNA isoforms have been identified in
Caco-2 cells; FPN1A and FPN1B, respectively [29]. Reporter
assays with luciferase reporter constructs containing 1Kb of either
the FPN1A or FPN1B 59-promoter indicated that FPN1A is the
dominant isoform in Caco-2 cells having 4-5 fold higher basal
activity than the FPN1B promoter (Figure 5A). However, there
was no effect of quercetin on the luciferase activity of either FPN
promoter construct (Figure 5 B,C).
Quercetin decreases 39-UTR reporter activity in Caco-2
cells
Polyphenols are known to be potent regulators of micro-RNA
(miRNA) expression and activity. We therefore investigated
whether quercetin might regulate FPN mRNA levels in Caco-2
cells via miRNA interaction with its 39UTR. In reporter assays in
Caco-2 cells transfected with a Renilla-luciferase reporter
construct containing the 39 UTR of human FPN, exposure to
quercetin significantly decreased reporter activity (Figure 6A).
Next we attempted to identify potential miRNA species that
might be involved in these regulatory events. First, we used arrays
to identify miRNA species up-regulated by quercetin in Caco-2
cells. Expression of 33 miRNAs were increased .1.5-fold in
quercetin-treated cells compared with untreated controls (Table
S2). Next we used web-based bioinformatics packages (TargetScan
www.targetscan.org; and miRBase www.mirbase.org) to determine
Figure 1. Acute effects of quercetin on intestinal iron transport. The acute effects of quercetin and its methylated analogues (3MQ, 49MQ,
3,49dMQ, PMQ) on iron transport in vivo were measured using the in situ duodenal loop method. 59Fe (0.2 mmol/L) and polyphenol (1 mmol/L) were
added to the lumenal uptake buffer and mucosal iron uptake (A) and mucosal transfer of iron into the circulation (B) measured. The effects of
quercetin on iron uptake across the apical membrane (C) and iron efflux across the basolateral membrane (D) of human intestinal Caco-2 cells was
also measured. Data are mean 6 SEM of 4 (rat duodenum) or 4–5 (Caco-2 cells) observations in each group. Groups with no common letters are
significantly different from each other (one-way ANOVA and Tukey’s post hoc test; P,0.05).
doi:10.1371/journal.pone.0102900.g001
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if any up-regulated miRNAs had consensus binding sites in the
human FPN 39-UTR (Table S3). Binding sites for 2 members of
the miR-17 family, miR-17-3p (bases 61-67 of the 39UTR
sequence) and miR-17-5p (2 sites at bases 1132-1138 and 1166-
1172), respectively, were present in the FPN 39UTR (Figure S2).
Finally, we used qPCR to validate the array data to determine
whether expression of the miR-17 species was altered following
quercetin treatment. miR-17-3p was strongly up-regulated in
quercetin-treated Caco-2 cells (Figure 6B). In contrast, there was
no significant effect of quercetin on the expression of miR-17-5p
(Figure 6C). Furthermore, expression levels of miR-485-3p, which
has 2 consensus binding sites in the FPN 39UTR (at bases 448-454
and 618–625, respectively) and has been shown to be involved in
the inhibition of FPN expression by iron deficiency in HepG2 cells
[30], were not altered in quercetin-treated Caco-2 cells
(Figure 6D).
Figure 2. Effects of longer-term exposure to quercetin on intestinal iron transporter expression. Rats (A) were given a single gavage
containing quercetin (50 mg/Kg body weight). Caco-2 cells (B & C) were exposed to quercetin (10 or 100 mM). After 18 h RNA was isolated from
duodenal tissue (A) and Caco-2 cells (B,C) and used to measure changes in iron transporter mRNA expression. (D,E) Whole cell protein was isolated
from Caco-2 cells and used for western blotting to measure DMT1 and FPN protein. Data are mean 6 SEM of 4 (rat duodenum) or 7-18 (Caco-2 cells)
observations in each group. (A) *P,0.05 compared with control group (Student’s unpaired t-test). (B – E) Groups with no common letters are
significantly different from each other (one-way ANOVA and Tukey’s post hoc test; P,0.05). No letters indicates no significant difference between any
of the groups.
doi:10.1371/journal.pone.0102900.g002
Table 1. Markers of iron status in control and quercetin-treated rats.
Control Quercetin-treated
Duodenal non-haem iron (mg/g dry weight) 22.961.2 (4) 32.561.5 (4)*
Serum iron (mg/dL) 140.9615.1 (4) 90.763.9 (4)*
Transferrin saturation (%) 27.662.5 (4) 18.961.0 (4)*
Liver hepcidin mRNA (a.u.) 0.660.3 (4) 0.260.1 (4)NS
Data are means 6 SEM (n). *P,0.05 compared with control group. NS Not significantly different from control group.
doi:10.1371/journal.pone.0102900.t001
Quercetin and Intestinal Iron Absorption
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Discussion
Several independent studies have established that polyphenols
significantly decrease non-haem iron absorption in duodenum
[13–17]; however, the exact mechanism of action is unknown.
Based on the data from our current study we discuss four possible
mechanisms that might underlie the inhibitory effects of quercetin
on intestinal iron transport: 1. Iron chelation; 2. Circulating iron
and hepcidin levels; 3. Cellular iron levels; 4. Direct effects of
quercetin on intestinal iron transporter expression.
Figure 3. Effects of longer-term exposure to quercetin on iron transport in Caco-2 cells. Caco-2 cells were exposed to quercetin (10 or
100 mM) for 18 h. Quercetin was removed by washing and cells were incubated in quercetin-free uptake buffer containing 59Fe. Uptake across the
apical membrane (A) and efflux across the basolateral membrane (B) was determined. Data are mean 6 SEM of 5-6 observations in each group.
Groups with no common letters are significantly different from each other (one-way ANOVA and Tukey’s post hoc test; P,0.05). No letters indicates
no significant difference between any of the groups.
doi:10.1371/journal.pone.0102900.g003
Figure 4. Effects of quercetin on ferritin protein levels in Caco-2 cells. Caco-2 cells were exposed to quercetin (10 or 100 mM) for 18 h. Cells
were solubilised and aqueous extracts used to measured cell ferritin protein content using a commercially available ELISA. Data are mean 6 SEM of
15 observations in each group. Groups with no common letters are significantly different from each other (one-way ANOVA and Tukey’s post hoc
test; P,0.05).
doi:10.1371/journal.pone.0102900.g004
Quercetin and Intestinal Iron Absorption
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1. Iron chelation
Our acute in vivo iron transport data demonstrated that
quercetin increases iron uptake and retention by the duodenal
mucosa. We argued that iron chelation by quercetin could play
important role in this phenomenon. It has previously been shown
that the preferred site for iron chelation by quercetin is between
the 3-hydroxyl and 4-carbonyl group; for complexes containing
one iron and one quercetin molecule, binding strength has an
order 3–4.4–5.39–49. Moreover, 3–4 chelation site is also
preferred for complexes which are formed between one iron and
two or three quercetin molecules [31]. We therefore performed
uptake experiments with quercetin aglycone, and methylated
forms of quercetin to determine whether replacing the putative
iron binding groups would influence transepithelial iron transport.
Our data clearly indicate that the greatest increase in transepi-
thelial iron transport was observed with compounds where 3-
hydroxyl groups were methylated (3MQ, 3,49dMQ and PMQ). In
contrast, when the 3-hydroxyl group was present, namely in
quercetin and 4MQ, there was a decrease in transepithelial iron
transport. These results demonstrate that chelation of iron by the
3-hydroxyl group of quercetin is an important determinate of iron
uptake in duodenum. Potentially this mode of action could be
ascribed to all dietary polyphenols that have demonstrable
capacity to chelate iron, for example (-)-epigallocatechin-3-gallate,
[16,32] and this information could be useful in the design of iron
chelators based on the structure of these common dietary
polyphenols.
The site of iron chelation by quercetin is unclear, i.e. whether
binding takes place in the intestinal lumen or within the cytosol of
the duodenal enterocytes. Quercetin aglycone can cross cell
membranes via facilitated glucose (GLUT) transporters [33,34]. In
addition, there is evidence from in vitro studies that quercetin-iron
chelates may also be transported via GLUTs [35]. Thus there is
scope for both lumenal and cytosolic iron chelation to lead to iron
accumulation within enterocytes. The increase in duodenal iron
content occurs largely as a consequence of a reduced rate of iron
Figure 5. Effects of quercetin on FPN promoter activity. Caco-2 cells were transfected with luciferase reporter constructs containing 1Kb of
either FPN1A or FPN1B 59 promoter, or with the empty PGL4 plasmid. Luciferase activity (normalised to renilla) arising from basal activity of the
promoters (A) and following exposure to quercetin (1 or 10 mM) for 18 h (B) was measured using the Dual Luciferase Reporter Assay (Promega). Data
are mean 6 SEM of 6-9 observations in each group. Groups with no common letters are significantly different from each other (one-way ANOVA and
Tukey’s post hoc test; P,0.05). No letters indicates no significant difference between any of the groups.
doi:10.1371/journal.pone.0102900.g005
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efflux across the basolateral membrane into the blood. It is possible
that intracellular quercetin-iron chelates might be too large to exit
enterocytes via FPN, though some efflux through basolateral
GLUTs remains a possibility. Furthermore, we cannot discount
the possibility that quercetin or its metabolites have direct
inhibitory effects on the function of FPN. Together these
mechanisms could account for the increased mucosal iron
retention observed in our studies.
2. Circulating iron and hepcidin levels
The longer term effects of quercetin on intestinal iron transport
are less well studied. Here we have shown that oral administration
of quercetin increased iron retention within the duodenum and
resulted in a decrease in serum iron and transferrin saturation
levels. In addition, there was a 60% decrease in liver hepcidin
mRNA expression in quercetin-treated rats. These findings are
consistent with previous data in rats fed an iron deficient diet [36];
however, crucially in this and previous studies iron deficiency was
associated with a significant increase in both DMT1 [36,37] and
FPN in the duodenum [10,36]. Furthermore, we and others have
shown previously that intestinal FPN and DMT1 expression are
down-regulated by prolonged exposure to elevated hepcidin levels
[38–42]. Taken together these data suggest that low circulating
iron and hepcidin levels do not mediate the inhibitory effects of
quercetin on intestinal iron transport observed in the current
study.
3. Cellular iron levels
The accumulation of iron in duodenal tissue observed in our in
vivo experiments with quercetin-fed rats might also result in
regulation of iron transporter expression. Previous studies in
animals given a bolus of iron by gavage demonstrated a decrease
in DMT1 expression [43–45]; however, iron efflux [43] and FPN
expression [45] were largely unaffected. Therefore, the increase in
Figure 6. Effects of quercetin on the activity of FPN 39 UTR. (A) Caco-2 cells were transfected with MISSION FPN 39-UTR-Renilla luciferase
reporter construct and exposed to quercetin (10 mM) for 18 h. (B-D) Quantitative PCR was used to determine the effects of quercetin on the
expression of candidate microRNAs predicted to interact with the FPN 39UTR. Data are mean 6 SEM of 5-6 observations in each group. *P,0.05
compared with control group (Student’s unpaired t-test).
doi:10.1371/journal.pone.0102900.g006
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duodenal iron accumulation in quercetin-fed rats is consistent with
the decrease in DMT1 expression but does not explain the
decrease in FPN.
The increase in duodenal iron content presents an apparent
paradox since in quercetin-treated Caco-2 cells there was a
significant decrease in levels of the iron storage protein ferritin,
which is indicative of functional cellular iron deficiency rather than
iron loading. In the cell culture model we envisage that cellular
iron is sequestered by some other molecular entity, most likely
quercetin. At this stage we do not know whether the iron retained
within the rat duodenal mucosa in our in vivo model is also
chelated by quercetin.
Even if we assume that quercetin treatment results in iron
deficiency in Caco-2 cells this still cannot explain the effects of
quercetin on transporter expression. We have shown that DMT1
expression in Caco-2 cells is decrease by iron [26;46] and
increased following exposure to the iron chelator desferrioxamine
(Figure S3). In contrast neither iron deficiency nor iron loading
had a significant effect on FPN mRNA expression.
4. Direct effect of quercetin on intestinal FPN expression
Finally, we addressed the possibility that quercetin directly
regulates FPN expression. In Caco-2 cells exposed to quercetin
there was a significant dose-dependent decrease in FPN protein
and mRNA and this was associated with a significant decrease in
iron transport across Caco-2 cell monolayers. To elucidate the
molecular mechanisms underlying these effects we employed
luciferase-reporter assays containing either the FPN 59-promoter
or its 39UTR. While there was no effect of quercetin on the
activity of 59-promoter, the activity of the 39UTR construct was
significantly decreased in the presence of quercetin. Regulation of
the stability of the 39UTR of mammalian mRNA has been shown
to be controlled by a number of mechanisms including interactions
with non-coding miRNA species. Interestingly, miRNAs have
been shown to play a role in modulating the expression of a
number of key players in iron homeostatic regulation, including
hepcidin (miR-122; [47]), DMT1 (Let-7d; [48]) and FPN (miR-
485-3p; [30]). While there was no significant effect of quercetin on
miR-485-3p expression in Caco-2 cells, we identified miR-17-3p
as a quercetin-induced candidate regulator of FPN mRNA
expression. Expression of miR-17-3p was elevated significantly
following exposure to quercetin, and bioinformatics identified a
consensus binding site for miR-17-3p (bases 61-67 of the 39UTR
sequence) in the human FPN 39UTR. The miR17 cluster is one of
the most widely studied in microRNA biology and has been shown
to play an important role in a number of biological processes in
both health and disease [49]. Our data suggest a role for miR-17
and potentially other microRNAs in mediating diet-gene interac-
tions that can influence nutrient bioavailability.
In summary, we have shown that quercetin can influence
intestinal iron absorption acutely through chelation of iron within
the intestinal lumen via its 3-hydroxyl group, and in the longer-
term through direct regulation of FPN transporter expression,
possibly through interactions between miRNA and 39UTR of FPN
mRNA. As potent inhibitors of iron bioavailability, diets rich in
polyphenols might be beneficial for groups at risk of iron loading
(e.g. patients with hereditary haemochromatosis), either by
limiting the rate of intestinal iron absorption or by modifying
tissue iron distribution. Further testing of quercetin and other
phenolic compounds with iron chelating and cell signalling
properties in animal models of iron overload could provide the
basis for novel approaches for treating clinical iron overload in
humans.
Supporting Information
Figure S1 Structures of quercetin and methylated-quercetin
analogues.
(TIF)
Figure S2 Predicted binding sites for miR17-3p, miR17-5p and
miR485-3p in human FPN 39UTR.
(TIF)
Figure S3 Effects of desferrioxamine (DFO) and iron (FAC) on
(A) DMT1 and (B) FPN mRNA expression in Caco-2 cells. Data
are mean 6 SEM of 5–6 observations in each group. Groups with
no common letters are significantly different from each other (one-
way ANOVA and Tukey’s post hoc test; P,0.05). No letters
indicates no significant difference between any of the groups.
(TIF)
Table S1 PCR primers used in the study.
(TIF)
Table S2 Fold changes (.1.5-fold) of human miRNA in Caco-2
cells exposed to 10 mM quercetin for 18 h. miRNA profiling was
performed using the GeneChip miRNA array (Affymetrix, UK),
which contains 847 specific probe sets for human miRNAs derived
from the Sanger miRBase miRNA database v11. Results from the
chip have been filtered to show human miRNA only and true
significant changes (p,0.05) when compared to untreated
controls.
(TIF)
Table S3 Predicted miRNAs interacting with FPN (SLC40A1);
top 30 by rank. Data are from miRBase www.mirbase.org. Both
miR17-3p (24th) and miR17-5p (12th) are among the top 30
miRNAs predicted to interact with the FPN 39UTR.
(TIF)
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